StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the stock. Cancer Genetics Price Performance Shares of CGIX opened at $0.18 on Wednesday. The stock’s fifty day moving average price is $0.26. Cancer Genetics has […]
StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. Cancer Genetics Stock Performance CGIX stock opened at $0.18 on Tuesday. The business’s 50-day moving average price is $0.26. The company has a market […]
StockNews.com started coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report published on Monday morning. The firm issued a sell rating on the stock. Cancer Genetics Price Performance Shares of CGIX opened at $0.18 on Monday. The firm has a market cap of $718,960.00, a P/E ratio of -0.09 and a […]
StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the stock. Cancer Genetics Price Performance NASDAQ CGIX opened at $0.18 on Friday. The stock’s fifty day moving average is $0.17. The firm has a market capitalization of $736,525.50, […]
StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Price Performance Shares of NASDAQ:CGIX opened at $0.18 on Friday. The stock has a market capitalization of $736,525.50, a PE ratio of […]